Xunhua Liu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.

PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.

Journal: Cancer science

Published: December 19, 2022

MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.

MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.

Journal: Nature communications

Published: December 06, 2022

LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis.

LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 30, 2022

LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.

LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.

Journal: EMBO reports

Published: October 08, 2021

RSL1D1 promotes the progression of colorectal cancer through RAN-mediated autophagy suppression.

RSL1D1 promotes the progression of colorectal cancer through RAN-mediated autophagy suppression.

Journal: Cell death & disease

Published: September 09, 2021

MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.

MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.

Journal: Experimental cell research

Published: December 24, 2020

CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.

CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.

Journal: Theranostics

Published: March 05, 2020

Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma

Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: May 16, 2015

Implementation of standard operation procedures for KRAS andBRAF gene mutation detection in colorectal cancer

Implementation of standard operation procedures for KRAS andBRAF gene mutation detection in colorectal cancer

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: March 14, 2015

An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer.

An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer.

Journal: Gut

Published: February 21, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026